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Highlights 23 
• Accumulating evidence has demonstrated a relationship between chronic 24 
periodontal diseases and atherosclerosis 25 
• Periodontal pathogens have been associated with atherosclerosis in apoE 26 
knockout mice. 27 







ABSTRACT  33 
 34 
The association between cardiovascular and periodontal diseases is characterized by 35 
chronic inflammatory processes, with a high prevalence worldwide and complex genetic-36 
environment interactions. Although apolipoprotein E4 (ApoE4), one of the isoforms coded by 37 
a polymorphic APOE gene, has been widely recognized as a risk factor for cardiovascular 38 
diseases and as an immunoinflammatory factor, but less is known regarding how ApoE4 39 
affects atherosclerosis in periodontitis patients. The aim of this review was to investigate the 40 
potential underlying mechanisms related to APOE4 that could increase the risk of 41 
periodontal disease and, ultimately, of atherosclerosis. There have only been a few studies 42 
addressing apoE polymorphisms in patients with chronic periodontitis. To date, no studies 43 
have been performed that have assessed how ApoE4 affects atherosclerotic disease in 44 
chronic periodontitis patients. Although clinical studies are warranted, experimental studies 45 
have consistently documented the presence of periodontal pathogens, which are usually 46 
found in the oral cavity and saliva, in the atherosclerotic plaques of ApoE-deficient mice. In 47 
addition, in this review, the potential role of the APOE4 allele as an example of antagonistic 48 
pleiotropy during human evolution and its relation to oral health is discussed.    49 
 50 
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1. Introduction 64 
Periodontal disease (PD) is a multifactorial, chronic, inflammatory disease, 65 
associated with bacterial plaque, gingival bleeding, edema and increased crevicular fluid 66 
formation that results from endotoxin bacteria-driven host immune responses. PD is 67 
characterized by the inflammation and destruction of tooth-supporting connective tissues in 68 
response to subgingival infection by various periodontal pathogens (Kinane, Stathopoulou, & 69 
Papapanou, 2017). Periodontitis pathophysiology is associated with a myriad of pro-70 
inflammatory cytokines, skewed towards Th1/Th17 responses (de Vries, Andreotta, Loos, & 71 
Nicu, 2017) and induced osteolysis (Goncalves, Evangelista, da Silva et al., 2014), the latter 72 
of which has been found to be reduced by simvastatin treatment (a cholesterol-lowering 73 
drug) (Dalcico, de Menezes, Deocleciano et al., 2013). 74 
Due to its chronic inflammatory etiology, a potential link between the occurrence of 75 
periodontal disease and atherosclerosis has been investigated (Cardoso, Reis, & 76 
Manzanares-Cespedes, 2018). Pioneer studies from Mattila and colleagues have suggested 77 
associations between myocardial infarction and poor oral health, which could be facilitated 78 
by chronic low grade bacterial infections (such as dental caries and chronic periodontitis) 79 
(Mattila, Nieminen, Valtonen et al., 1989). However, the determination of a causative effect 80 
has been hampered because patients with chronic illnesses (including metabolic syndrome 81 
and diabetes) are also likely to be affected by periodontitis. However, in the studies reported 82 
by Mattila, poor oral health was a predictor of myocardial infarction, even after adjusting for 83 
age, social class, hypertension, serum lipid and lipoprotein concentrations, smoking, the 84 
presence of diabetes, and serum C peptide concentrations (Mattila, Nieminen, Valtonen et 85 
al., 1989).    86 
The complications associated with atherosclerosis and metabolic syndrome are 87 
recognized as worrisome public health problems in developing countries and may especially 88 
affect populations with nutritional and immunoinflammatory disorders, with the likelihood of 89 
increased fatalities (DeBoer, Lima, Oria et al., 2012; Teo & Dokainish, 2017). The systemic 90 
inflammatory processes (even those that are low-grade) induced by chronic periodontal 91 
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disease (Cardoso, Reis, & Manzanares-Cespedes, 2018) may be related to peripheral 92 
arterial (and endothelial) inflammatory conditions (Calapkorur, Alkan, Tasdemir et al., 2017), 93 
which may further elevate the risks of atherosclerosis, coronary disease, myocardial 94 
infarction, and death. 95 
Cardiovascular diseases (CVD) and periodontal disease share genetic bases of 96 
susceptibility and important behavioral components, such as diet, plaque control and 97 
smoking-related habits. Studies have shown that both conditions increase with age, lower 98 
socioeconomic strata and poor educational background, especially for males, the diabetic 99 
population, and individuals undergoing psychological stress or who have a significant 100 
genetic predisposition (Nazir, 2017).  101 
Apolipoprotein E (ApoE=protein; APOE=gene) is a glycoprotein synthesized in the 102 
liver that plays a key role in the catabolism of triglycerides and cholesterol. In addition, ApoE 103 
plays a pivotal role in different inflammatory conditions (Azevedo, Bolick, Roche et al., 2014; 104 
Azevedo, Oliveira, Oliveira et al., 2012). In animal models, an ApoE deficiency can lead to 105 
increased lipid levels in the bloodstream, even under chow diet conditions. In addition, 106 
APOE null mice have been extensively used as animal models for atherosclerosis, as these 107 
mice accumulate atheroma in the aortae when chronically fed with cholesterol-enriched diets 108 
(Getz & Reardon, 2016).  109 
In this review, recent findings were discussed, highlighting how different ApoE 110 
isotypes may affect atherosclerosis in patients with periodontal disease,  and discuss about 111 
the use of APOE knockout mice as tool for understanding how oral pathogens can be 112 
translocated and their effects on the atherosclerotic plaque. Finally, it was speculated that 113 
the APOE4 allele may play a potential role as an example of antagonistic pleiotropy during 114 
human evolution in relation to oral health. Antagonistic pleiotropy is an evolutionary theory 115 
(Gaillard & Lemaitre, 2017) that postulates that certain genes or alleles may differentially 116 





2. Periodontal and cardiovascular diseases 120 
Teeth are supported by a connective tissue attachment apparatus (periodontal 121 
ligament), which is partly inserted into the outer layer of the root surface (root cementum) 122 
and partly into the bone of the maxillary or mandibular alveolar processes, and, to a lesser 123 
extent, by the gingival tissues that surround the teeth (Cho & Garant, 2000).  124 
In periodontal disease, inflammatory processes induced by microbes result in the 125 
formation of a periodontal pocket with the apical migration of both the gingival attachment to 126 
the root surface and the plaque biofilm, gingival recession and alveolar bone resorption 127 
(Hajishengallis & Sahingur, 2014).  128 
According to the WHO, severe periodontal disease affects 15% to 20% of the middle-129 
aged global population (35–44 years of age) and may cause 5% to 15% of total tooth loss. 130 
Approximately 50% of periodontal diseases have been attributed to genetic variance 131 
(Rajendra Santosh, Ogle, Williams, & Woodbine, 2017).  132 
Atherosclerosis or atherosclerotic vascular disease is a chronic inflammatory process 133 
characterized by the progressive accumulation of atheroma plaques in the vessel 134 
endothelium, which originate from inflammatory responses and immune system activation 135 
(Nguyen, Kim, Quan et al., 2015).  136 
 Oral infections may interfere with vascular, endothelial, and smooth muscle cell 137 
biology, which could cause predisposition to atherosclerosis (Chistiakov, Orekhov, & 138 
Bobryshev, 2016). Oral pathogen-related inflammation can promote pro-coagulant effects, 139 
followed by greater scavenger receptor (SR) A and CD36 expression and activity by 140 
macrophages. (Baer, Huang, & Gibson, III, 2009) The uptake of cholesterol-rich LDL was 141 
also related to the increased expression of cell-adhesion molecules (such as integrin CD49c 142 
(α3-subunit) in monocytes) (Escate, Padro, & Badimon, 2016). In addition, smooth muscle 143 
cell proliferation, migration and anti-apoptosis machinery can be upregulated after exposure 144 
to certain oral pathogens, such as Porphyromonas gingivalis, which are known to induce 145 
pro-inflammatory cytokines in periodontal tissues (Naruishi & Nagata, 2018; Teles & Wang, 146 
2011). Furthermore, oral pathogens may exert pro-atherosclerotic effects by activating the 147 
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uptake of oxidized LDL (LDLox) and the production of pro-inflammatory cytokines (such as 148 
TNF, IL-6 and IL1-β) and transforming macrophages in "foam cells". The migration of other 149 
leukocyte subtypes (such as lymphocytes) contributes to the increased inflammatory status 150 
and leads to atherosclerotic plaque instability and rupture (Nguyen, Kim, Quan et al., 2015).  151 
 Chronic inflammatory processes driven by the periodontal biofilm may be facilitated 152 
by complex host-pathogen interactions (e.g., worsened by immunosuppression and 153 
pathogenic virulence). Multiple risk factors, such as age, CVD familial history, dyslipidemia, 154 
smoking, systemic arterial hypertension, sedentary lifestyle, diabetes mellitus and being 155 
overweight may debilitate the host and create an appropriate scenario for a pro-atherogenic 156 
effect that is spread by oral pathogens (Chistiakov, Orekhov, & Bobryshev, 2016; Lockhart, 157 
Bolger, Papapanou et al., 2012).  158 
 The American Heart Association's Committee on Rheumatic Fever, Endocarditis, and 159 
Kawasaki Disease (1992) reviewed several risk factors and found a strong association 160 
between atherosclerotic vascular disease (ASVD) and PD that was independent of known 161 
confounders. However, it was not possible to demonstrate causality between these two 162 
disorders. Therefore, therapeutic interventions for PD cannot be considered to prevent 163 
ASVD-related events at this stage (Lockhart, Bolger, Papapanou et al., 2012). In a robust 164 
meta-analysis of 15 observational studies involving 17,330 patients, Zeng et al. (Zeng, Leng, 165 
Lam et al., 2016) found that periodontal disease was an independent risk factor for 166 
atherosclerosis, although these authors reported substantial statistical heterogeneity in their 167 
studies 168 
Ahn and colleagues (Ahn, Shin, Han et al., 2016) studied the association between 169 
PD and atherosclerosis in an adult Korean population, using carotid intima-media thickness 170 
(cIMT) and ankle-brachial index (ABI) as markers of central arterial and lower extremity 171 
stenosis, respectively. The authors observed that periodontitis was associated with 172 
subclinical atherosclerosis and peripheral arterial disease after adjusting for age, gender, 173 
education level, smoking, drinking, exercise, central obesity, triglycerides, HDL, LDL, hs-174 
CRP, diabetes and hypertension (Ahn, Shin, Han et al., 2016). These results are consistent 175 
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with previous studies showing independent associations between periodontitis and both 176 
subclinical atherosclerosis (SA) and peripheral arterial disease (PAD), which represent early 177 
atherosclerotic vascular changes (Ahn, Shin, Han et al., 2016)  178 
The biological mechanism through which PD contributes to atherosclerosis may 179 
involve direct bacterial effects on platelets, autoimmune responses, the bacterial invasion of 180 
endothelial cells and the systemic upregulation of pro-inflammatory mediators (Gurav, 2014). 181 
Periodontal infection results in a chronic low-grade bacteremia, which induces both local (at 182 
the blood vessel wall) and systemic inflammatory cytokine upregulation, such as IL-1β, IL-183 
12, IL-18 and TNF-α, causing the increased expression of adhesion molecules and the 184 
release of leukocyte chemotactic chemokines, such as MCP-1/CCL2, by the endothelium 185 
(Teles & Wang, 2011). The subsequent chemoattracted leukocyte infiltration and cytokine 186 
release into the vessel wall lead to endothelial dysfunction, increasing the likelihood of 187 
atherosclerotic plaque formation, which can be detected at the early stages of an 188 
atherosclerotic lesion by the thickening of the carotid wall and the decreased patency of 189 
arteries in extremities (Ahn, Shin, Han et al., 2016). Hence, longer and more severe chronic 190 
periodontitis increases the risks of experiencing an atherogenic effect (Ahn, Shin, Han et al., 191 
2016) in predisposed and at-risk individuals.  192 
In a cohort of 106 patients with a diagnosis of ischemic stroke or transient ischemic 193 
attack (TIA) that were screened for periodontal disease, 27 reported recurrent vascular 194 
events (16 with TIA or ischemic stroke) at the 24-month follow-up. However, a survey 195 
demonstrated that there was an important association between increased aortic arch 196 
atheroma (AA) plaque thickness and calcification in patients with advanced PD (Sen, Chung, 197 
Duda et al., 2017). Thus, in this study, the authors concluded that, in patients with TIA or 198 
ischemic stroke, PD at an advanced stage is associated with an increase in the AA plaque 199 
thickness and is therefore, an important risk factor for recurrent vascular events (Sen, 200 





3. ApoE, periodontal disease and atherosclerosis 204 
ApoE is a 34 KDa glycoprotein, discovered in 1970, composed of 299 amino acids 205 
and synthesized primarily by the liver and exported to the plasma. ApoE is an important 206 
component of all lipoproteins, except LDL, and is involved in the redistribution of triglycerides 207 
and cholesterol in various tissues (Mahley, 2016). ApoE, similar to other apoproteins, helps 208 
to stabilize and solubilize lipoproteins while circulating in the blood. In general, the role of 209 
ApoE in lipid metabolism includes maintaining the integrity of the lipoprotein structure and 210 
acting as a ligand for lipoprotein receptors (Mahley, 2016). 211 
The APOE gene is polymorphic, with the three most common alleles being the 212 
epsilons E2, E3 and E4 (Huebbe & Rimbach, 2017). Point mutations in the codons result in 213 
either a cysteine or arginine residue at positions 112 and 158. In the E2-coded ApoE allele, 214 
cysteine amino acids are found at both positions; in the E3-coded ApoE allele, there is a 215 
cysteine at position 112 and an arginine at position 158; and in the E4-coded ApoE allele, 216 
arginine is found at both positions. The frequency of the E2, E3 and E4 alleles vary widely 217 
between different populations, although the E3 allele is the most common, followed by E4 218 
and E2 (Mendes-Lana, Pena, Freitas et al., 2007; Riemenschneider, Schwarz, Wagenpfeil et 219 
al., 2002). The E4 allele is considered to be the ancestral allele. In addition to these 3 220 
isotypes, there are other rarer ApoE variants, such as E1, E5 and E7 (Gerdes, 2003). 221 
These modifications of the ApoE isoforms are able to differentially influence lipid 222 
metabolism. Due to the tertiary structural conformations of the ApoE molecules (E3= cys-223 
112, arg-158; E3= cys-112, arg-158; E4= arg-112, arg-158), distinct binding forces exist for 224 
the ApoE isoforms, either with the LDL receptor or with heparan sulfate proteoglycans 225 
(HSPGs), which are important for cholesterol metabolism. These interactions affect lipid 226 
levels, with the ApoE4 allele being more associated with increased total cholesterol (rather 227 
than ApoE3 and ApoE3) and increasing the risk for cardiovascular diseases. Helix 4 of the 228 
ApoE structure contains the LDL-receptor binding region (residues 136-150). In the ApoE 3 229 
and 4 isoforms, the arginine at residue 158 builds a salt bridge with the aspartate at residue 230 
154, allowing the arginine at residue 150 to remain in the highly basic region of the receptor 231 
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binding site. A diagram of the ApoE isoforms is depicted in Figure 1. Conversely, in the 232 
ApoE2 isoform, the cysteine at residue 158 does not bind to aspartate and, therefore, 233 
aspartate is allowed to bind to the arginine at residue 150, which is external to the binding 234 
site. As a consequence, the ApoE2 isoform has the lowest binding affinity to the LDL 235 
receptor.  236 
Kesaniemi and colleagues were the first to report that the E4 phenotype is associated 237 
with an increased intestinal absorption of cholesterol (Kesaniemi, Ehnholm, & Miettinen, 238 
1987). APOE4 is associated with increased cholesterol, low-density lipoprotein (LDL) and 239 
apolipoprotein B levels, effects which can lead to atherosclerosis, hyperlipidemia and 240 
cardiovascular diseases (Eichner, Dunn, Perveen et al., 2002). An increase in the level of 241 
LDL in the systemic circulation can activate endothelial cells and build an inflammatory 242 
response, which culminates in macrophage recruitment and atherosclerosis formation. This 243 
process is accelerated by an adjacent inflammatory disease, such as PD (Finch & Morgan, 244 
2007; Huebbe, Nebel, Siegert et al., 2011).  245 
In a meta-analysis, including 4,564 coronary artery disease (CAD) cases and 3,985 246 
controls, Yin et al. (2013) documented an association between the E4 allele and an increase 247 
in the CAD risk of a Chinese population, accumulating valid evidence (Yin, Sun, Zhang et al., 248 
2013). 249 
Bergdah and colleagues (2008) reported on dentate and edentulous individuals and 250 
related sociodemographic data, including years of education, age and living conditions. 251 
These authors found that APOE4 was found significantly more frequently in the edentulous 252 
group (Bergdahl, Bergdahl, Nyberg, & Nilsson, 2008). However, in a Chinese case/control 253 
study, Gao and colleagues found that individuals expressing APOE-rs429358-CC/CT had 254 
decreased odds for generalized aggressive periodontitis when compared with individuals 255 
expressing the APOE-rs429358-TT polymorphism, after controlling for age, sex, BMI and 256 
smoking status (Gao, Tian, Meng et al., 2015).  257 
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These results have raised questions regarding whether genetic factors, such as 258 
APOE4, might contribute to an increased risk of developing complex dental diseases that 259 
lead to tooth loss, which is an undesirable outcome for any individuals.  260 
Interestingly, vitamin D deficiency has been associated with chronic periodontitis 261 
(Abreu, Tatakis, Elias-Boneta et al., 2016). Vitamin D is considered an important 262 
immunomodulatory factor, regulating immune responses in the gingival epithelium and 263 
influencing the degree of host responses to P. gingivalis (De, Fiorentino, Guida et al., 2017; 264 
Huebbe, Nebel, Siegert et al., 2011).  265 
In addition, APOE4 has been associated with an improvement in urinary vitamin D 266 
reuptake and a more efficient UVB-induced conversion of pro-vitamin D in the skin (Gerdes, 267 
2003). Because APOE4 carriers have been found to have high levels of vitamin D, it can be 268 
speculated that APOE4 could protect against periodontal diseases in vitamin D-deficient 269 
endemic areas (Huebbe, Nebel, Siegert et al., 2011).  270 
Although the relationships between APOE4 and cardiovascular diseases are better 271 
known, the existence of an APOE4 risk factor for stroke is controversial (Tang, Amiesimaka, 272 
Harrison et al., 2018); however, this allele has been associated with subclinical 273 
atherosclerotic changes (Doliner, Dong, Blanton et al., 2018) and stroke-related mortality 274 
(Rajan, Aggarwal, Schneider et al., 2016).  275 
A model of the potential interactions between APOE4, periodontitis and 276 
atherosclerosis is shown in Figure 2.  277 
 278 
4. Oral infection and risk factors for atherosclerosis in animal models 279 
Studies in atherosclerotic-prone mice have suggested that oral pathogens influence 280 
the onset and progression of atherosclerosis (Chukkapalli, Rivera, Velsko et al., 2014), as 281 
shown by increased lipid accumulation in the arterial wall, macrophage infiltration, atheroma 282 
plaques, and inflammatory responses (Kebschull, Demmer, & Papapanou, 2010; 283 
Tuomainen, Jauhiainen, Kovanen et al., 2008).  284 
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The intraoral inoculation of Treponema denticola in 12- and 24-week-old ApoE -/- 285 
mice causes chronic oral infection and, consequently, chronic periodontitis, which shows that 286 
this pathogen has a strong relationship with periodontal disease and the progression of 287 
atherosclerotic disease (Chukkapalli, Rivera, Velsko et al., 2014).  288 
Decreased HDL levels and increased total and LDL cholesterol serum levels, along 289 
with systemic inflammatory markers, such as C-reactive protein (CRP) and interleukin-6 (IL-290 
6), may increase the risk of atherosclerosis (Ferri, Paoletti, & Corsini, 2006; Hermus, 291 
Lefrandt, Tio et al., 2010). In the ApoE -/- mouse model, mice subjected to a hyperlipidemic 292 
diet and treated with Fusobacterium nucleatum showed significantly higher CRP, LDL and 293 
IL-6 plasma levels, as well as lower levels of HDL, when compared with controls without F. 294 
nucleatum administration (Lee, Jun, Kim et al., 2012). However, oral pathogens, such as P. 295 
gingivalis, altered vascular responsiveness, mediated by alpha-adrenoceptors, which may 296 
not only cause periodontitis but also atherosclerosis (Gibson, III, Hong, Chou et al., 2004; 297 
Lalla, Lamster, Hofmann et al., 2003; Miyauchi, Maekawa, Aoki et al., 2012; Pereira, 298 
Vasquez, Stefanon, & Meyrelles, 2011).  299 
Some authors have indicated that the development of atherosclerosis in ApoE-300 
deficient mice infected with P. gingivalis could be prevented and inhibited by the employment 301 
of vaccination and human β-defensin-3 (Gibson, III, Hong, Chou et al., 2004; Li, Messas, 302 
Batista, Jr. et al., 2002). In another study, using the same experimental model, a significant 303 
40% increase in the area of the atherosclerotic lesion was identified in the aortic sinus when 304 
compared with the uninfected group (Lalla, Lamster, Hofmann et al., 2003). The 305 
advancement of atherosclerosis was also present in an ApoE-deficient murine model 306 
infected with this bacterium (Li, Messas, Batista, Jr. et al., 2002).  307 
The immune response of polybacterial infections (P. gingivalis, T. denticola, T. 308 
forsythia and F. nucleatum) in ApoE null mouse models is different from those observed for 309 
individual (monobacterial) infections (Rivera, Lee, Aneja et al., 2013). Polybacterial 310 
infections exhibited synergism, inducing a significant increase in plasma risk factors, such as 311 
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oxidized LDL, nitric oxide, altered lipid profiles and the formation of aortic plaques 312 
(Chukkapalli, Rivera, Velsko et al., 2014; Velsko, Chukkapalli, Rivera-Kweh et al., 2015).  313 
In another study, using the same mice models and polymicrobial infections, three of 314 
these bacterial strains, with the exception of F. nucleatum, were found to result in a 315 
significant association between PD and atherosclerotic disease, and the presence of a 316 
polymicrobial infection by both areas of the aorta was identified in several of the infected 317 
mice through the PCR analysis of thoracic and abdominal aorta samples (Cui, Li, Lei et al., 318 
2016; Rivera, Lee, Aneja et al., 2013), demonstrating that periodontitis caused by binding in 319 
experimental models may trigger an inflammatory response in the vascular wall and that 320 
nonsurgical periodontal treatment during the early stages of atherosclerosis can reduce 321 
systemic inflammation, improving the lipid profile (Cui, Li, Lei et al., 2016). 322 
To date, preclinical studies have consistently demonstrated that periodontal 323 
pathogens are able to translocate from the oral microbiota to atherosclerotic plaques in 324 
ApoE-deficient mice (see Table 1 for a summary of the revised literature relating 325 
periodontitis pathogens and atherosclerotic lesions). However, only three studies have 326 
reported on the effects of APOE polymorphisms in individuals with oral diseases and their 327 
associations with cardiovascular risk (Table 2). 328 
 329 
5. APOE4, a candidate gene for antagonistic pleiotropy in oral infections?  330 
Cohort studies in Brazilian shantytown communities with poor hygiene and sanitation 331 
have highlighted a protective role for the APOE4 allele in children with a history of heavy 332 
diarrhea illnesses during the first years of life in areas endemic for enteric infections and 333 
malnutrition (Oria, Patrick, Oria et al., 2010; Oria, Patrick, Zhang et al., 2005). The APOE4 334 
allele was associated with improved cognitive scores (in a subset of children with heavy 335 
diarrheal burdens), even though APOE4 is considered to be deleterious and to increase the 336 
risk of developing Alzheimer’s disease later in life (Kim, Basak, & Holtzman, 2009; 337 
Strittmatter, 2001; Yamazaki, Painter, Bu, & Kanekiyo, 2016). These initial studies were 338 
supported by findings from the Bolivian Tsimane populations, which are highly exposed to 339 
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enteric infections, where APOE4 was associated with lower C-reactive protein (CRP) serum 340 
levels (Vasunilashorn, Finch, Crimmins et al., 2011), which is a marker of systemic 341 
inflammation, suggesting reduced infection-driven inflammatory responses.  342 
In another study from the same group, non-APOE4 carriers with a high parasite 343 
burden (those with high IgE serum levels) showed a reduction in cognitive performance, 344 
which was not observed in APOE4 carriers (Trumble, Stieglitz, Blackwell et al., 2017). These 345 
studies suggest that APOE4 might display an antagonistic pleiotropy effect, which means it 346 
may be helpful early in life during environmental challenges, such as enteric infections and 347 
malnutrition (which prevail in nonindustrialized human civilization). This idea suggests that 348 
APOE4 is better fitted for traits related to protection against pathogens and improved fertility 349 
(van, Koopman, Bodegom et al., 2017a); however, later in life, it is known to be detrimental 350 
during aging-related diseases (Finch & Morgan, 2007). This same premise may be applied 351 
to oral infections. Precivilized meat hunters were likely afflicted with 352 
severe dental diseases (and enteric diseases) and oral microbiota changes (Weyrich, 353 
Duchene, Soubrier et al., 2017) but did not live long enough to develop age-related 354 
cardiovascular and Alzheimer’s diseases. Therefore, it can be speculated that APOE4 might 355 
have played a significant role in this protection. The relationships between APOE4 carriers 356 
and the oral microbiota and dental diseases, both during early life and with aging, require 357 
further investigation, particularly in regard to western diets. In addition, the associations 358 
between APOE4, periodontal diseases and Alzheimer’s disease still require further research. 359 
One study has documented associations between a low number of teeth, a low level of 360 
APOE4 and lower delayed word recall scores in elderly patients in Milwaukee, WI, USA 361 
(Stein, Kryscio, Desrosiers et al., 2010).  362 
The interactions between chronic cardiovascular disease, Alzheimer’s disease and 363 
periodontitis still remain an unexplored field, and research initiatives are unfortunately 364 
unrepresented in worldwide populations, especially in the developing world. A diagram of 365 




6. Summary 368 
The direct causality between atherosclerosis and periodontal diseases is challenging 369 
to dissect, due to common etiological roots, such as aging, life-style (diet, sedentarism), and 370 
immune-inflammatory and genetic factors. Apolipoprotein E4 (APOE4) is an attractive gene 371 
because it has been extensively associated with increased risks and worse outcomes for 372 
cardiovascular diseases.  373 
In human evolution, APOE4 is considered to be the ancestral APOE allele, and its 374 
preservation in our genetic pool may be related to its role in improving infectious diseases, 375 
which were ubiquitous in the preindustrialized era (Oria, Patrick, Blackman et al., 2007; 376 
Trumble, Stieglitz, Blackwell et al., 2017). Therefore, the occurrence of APOE4 might be an 377 
example of antagonistic pleiotropy, as this gene may be protective under heavy burdens of 378 
enteric infections and an adverse environment (by raising innate immunity and inflammation 379 
(Gale, Gao, Mikacenic et al., 2014)) early in life (Oria, Patrick, Zhang et al., 2005; van, 380 
Koopman, Bodegom et al., 2017a), while being deleterious during aging, contributing to 381 
atherosclerosis if one lives long enough in western societies. The antagonistic pleiotropy of 382 
genes related to worse CAD outcomes (such as APOE4) are designed for adverse 383 
environments during human evolution, which have been reported previously (Corbett, 384 
Courtiol, Lummaa et al., 2018; van, Koopman, Bodegom et al., 2017b).    385 
Early human populations were also often afflicted with chronic dental diseases and 386 
related-oral infections (in the preantimicrobial therapy era), for which APOE4 would be 387 
potentially protective (this unexplored area deserves attention in future studies); however, 388 
with this trade-off, individuals become more prone to later cardiovascular diseases if one 389 
lives long enough, as we have observed in modern times in western societies. The lack of 390 
long-term cohorts and clinical studies examining APOE polymorphisms, especially in 391 
deprived countries, have hampered the understanding of how APOE4 affects oral pathogens 392 
and related inflammatory responses and how these affects could be associated with 393 
atherosclerotic plaques. Studies performed in both clinical settings and using APOE4 target-394 
replacement mice are required. Long-term cohort studies with larger sample numbers in 395 
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developing countries and humanized APOE4 knock-in mice are warranted to evaluate the 396 
causal association between APOE4, PD and atherosclerosis, especially when considering 397 
the periodontal biofilm and its potential atherogenic effects.  398 
In addition, currently, clinicians aim for minimally invasive strategies to manage 399 
dental diseases. Over the years, when older patients enter a restorative cycle, as a 400 
consequence of a series of traditionally invasive approaches, and present a high disease 401 
burden, early detection and prevention are the keys to managing dental diseases. APOE4 402 
could be a marker for dental diseases and for chronic systematic diseases. Therefore, 403 
further laboratory and clinical studies are required to investigate these effects. 404 
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